1. Introduction
===============

Infections disease is one of the major causes of mortality in elderly populations because of decreases in cell-mediated immune responses ([@BIB66]). Zinc may be crucial in this respect, because of its requirement as a catalytic component of more than 300 enzymes, as a structural constituent of many proteins, and as a regulatory ion for the stability of proteins and in preventing free radical formation ([@BIB51]). This has led to recognition of zinc as a leading element in assuring correct functioning of various tissues, organs and systems, including immune responses ([@BIB92] [@BIB53]). In the role of catalyst, zinc polarises the substrate activating H~2~O molecules, which then act as a nucleophile. Zinc ions act as a template to bring together the substrate and the nucleophile, thereby accelerating the conversion of substrate to product ([@BIB89]). In a regulatory role, zinc determines the balance between gene expression of metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) ([@BIB63]) as well as all phases of the cell cycle by means of cyclin/CDK complex gene expression ([@BIB40]). In particular, zinc is most important in the G0/G1 phase. High doses of zinc (900 μM) arrest the cell cycle ([@BIB64]) whereas, low doses (150 μM) inhibit apoptosis in ageing in the G0/G1 phase ([@BIB72]). This last point is crucial for ageing and infections because their immune decrement is likely due to low zinc ions bioavailability with subsequent immune cell-death ([@BIB79]).

However, the main task of zinc is in a structural role because of the involvement of zinc finger, DNA domains of many proteins, peptides, enzymes, hormones, transcriptional factors and growth factors, including cytokines, relevant to the maintenance of body homeostatic mechanisms affecting, as such, gene transcription ([@BIB15], [@BIB3], [@BIB74]). Zinc also regulates gene expression by affecting mRNA stability ([@BIB85]) and by maintaining the extracellular matrix ([@BIB89]). Moreover, zinc binds enzymes, proteins and peptides with different affinity (kd) ranging from 10^−2^ to 10^−14^ mol/l ([@BIB53]), including a thymic hormone called thymulin (kd = 5.0 ± 2 × l0^−7^ mol/l) ([@BIB20]). The compounds are inactive or with low biological activity when zinc-binding does not occur ([@BIB51]). Zinc also plays a critical role in the structure, function, stabilisation and fluidity of biomembranes because of zinc binding to sulphydryl groups forming mercaptides ([@BIB4]). It is of interest, that zinc is also required to maintain optimal functional and enzymatic activity of inducible nitric-oxide synthase (iNOS) with consequent nitric oxide (NO) production, in turn, relevant in immune responses and cytokine activity ([@BIB7]). In fact, zinc is bound to two cysteine residues: part of crystal structures of the heme domain of iNOS maintaining integrity of the cofactor (tetrahydrobiopterin) binding site of iNOS ([@BIB44]). Because: i) NO is involved in metallothioneins (MTs) mRNA expression in the liver and hence protection against oxidative stress during inflammation ([@BIB2]) and ii) NO prevents cell-death activating a nuclear enzyme, poly (ADP-ribose) polymerase (PARP), which in turn requires two zinc finger motifs ([@BIB87]), the structural task of zinc in NO production is crucial. In addition, NO is involved in zinc release from MTs to antioxidant enzymes ([@BIB47]).

Pro-inflammatory cytokines (IL-1 and IL-6) affect MT mRNA ([@BIB18]). IL-1, IL-6, MTs, NO are increased during ageing and infections, whereas, zinc and immune efficacy are decreased ([@BIB53], [@BIB12]) with consequent immune cell-death by activating PARP ([@BIB83], [@BIB68]). Since infections are common event in elderly ([@BIB66]), subsequent mortality may occur because of the poor efficacy of conventional therapies in elderly populations ([@BIB58]). Therefore, increasing zinc bioavailability by supplementing zinc may be of benefit for immunoresistance to infections in ageing involving a new mechanism of homeostasis among pro-inflammatory cytokines, MTs, NO and PARP (as all these factors are zinc-dependent and implicated in immune efficiency ([@BIB55])).

This review considers the efficacy of zinc supply in immune responses during ageing and accelerated ageing (e.g., Down\'s syndrome), as well as the main biochemical pathways of zinc, including MTs-NO-PARP homeostasis, as crucial to immunoresistance to infections in ageing. An emphasis on cytokines in ageing is described because this is altered in ageing ([@BIB73]) and is involved in many biochemical pathways of zinc immunobiology ([@BIB92], [@BIB73]).

2. Zinc, infections and ageing: the role of cytokines
=====================================================

Many data support the view that the impact of zinc on immunocompetence is greater in cell-mediated immunity than humoral ([@BIB92]). In particular, chemotaxis by neutrophils and monocytes, thymic endocrine activity, antigen presentation by MHC class II molecules, natural killer (NK) activity, cytokine production and the Th1/Th2 balance are the immune functions most affected by zinc ([@BIB70]), as well as Th3 cells ([@BIB55]). In this context, cytokine production is peculiar, because of their different synthesis by Th1 or Th2 or Th3 cells. According to their function in cell-mediated immunity (Th1), in antibody mediated immunity (Th2) and in suppression (Th3), Th1 cells produce IL-2, IFN-gamma and TNF-alpha, Th2 cells produce IL-4, IL-5, IL-6, IL-10 and IL-13 ([@BIB75]), whereas, Th3 cells produce TGF-beta ([@BIB16]). Zinc may more directly affect Th1 cells, rather than Th2 cells, by means of MHC-complexes, or by thymic hormones or by immunomodulating hormones (melatonin, thyroid hormones, IGF-I or growth hormone) ([@BIB53], [@BIB70]), whereas zinc affects Th3 cells by zinc finger DNA domains, such as Egr-1 ([@BIB94]). Although a specific role of Th3 has not been reported in zinc deficiency, an increment of TGF-beta is observed in infections ([@BIB28]) as well as in ageing related to inflammation ([@BIB50]), and an imbalance of Th1/Th2 activity towards Th2 is usual in ageing and infections both characterised by zinc deficiency ([@BIB70]). Therefore a Th1/Th2 imbalance may also have to include consideration of the Th3 cells as well, as recently suggested in infections ([@BIB16]). In vivo and in vitro experiments in old ([@BIB32]) and infected mice ([@BIB76]) show that the imbalance of Th1/Th2 cytokines and TGF-beta production by Th3 cells is under the control of IL-12 produced by macrophages and resulting in decreased resistance to infections. In fact, IL-12 synthesis, which is required for Th1 development, is suppressed by increased IL-4 and TGF-beta in infected mice ([@BIB76], [@BIB33]) and Th1 cells ([@BIB73]) and IL-12 ([@BIB27], [@BIB45]) are decreased in ageing. On the other hand, activated TGF-beta has an important effect on pathogen entry, replication, persistence and latency ([@BIB28]). Because of zinc affecting IL-12 production ([@BIB22]), the balance of Th1/Th2 cells with also Th3 for the immunoresistance to infections may be controlled by zinc turnover, the alteration of which may cause decreased resistance to infections in old age with consequent high mortality. Supplementing zinc may be of benefit to restore the Th1/Th2 balance in ageing and infections, as documented in elderly people ([@BIB11]) and in nematode-infected mice ([@BIB80]). Although no data on the effects of zinc supplementation on TGF-beta are available, indirect evidence showing resistance to listeriosis in mice by an increment of IL-12, TNF-alpha and IFN-gamma by Th1 and by a decrement of TGF-beta after anti-CD1 mAb treatment ([@BIB84]), strongly support the possible involvement of zinc turnover in immunoresistance, because all these cytokines are directly or indirectly under the control of zinc turnover ([@BIB26]).

3. Therapeutic use of zinc in infections during ageing
======================================================

The relevant role played by zinc deficiency in immune decrements during infections and ageing is well documented during the last decade ([@BIB92] [@BIB70], [@BIB53]). However, there are dispersions of data due to the great variability in habitat conditions, in health status and individual dietary attitudes ([@BIB23]). This leads to considering zinc deficiency related more to the single individual\'s particular status rather than to the general effects of alterations of zinc-dependent factors with subsequent possible low zinc ion bioavailability for immune responses. Indeed, some investigators have reported normal zinc content both in the circulation and in lymphocytes during ageing ([@BIB71]). Therefore, supplementing zinc is not recommended by them. This is misleading because zinc is bound to many enzymes and proteins ([@BIB51]). Since atomic absorption spectrophotometry (AAS) assesses bound and unbound zinc, the real zinc ion bioavailability is not evident when using this technique ([@BIB53]). Although ecto-5 nucleotidase may be useful to examine zinc deficiency ([@BIB71]), specific methodological procedures to detect free zinc ions in plasma and tissues are not available, because zinc binds to more than 300 enzymes. We have developed a methodological procedure for testing active zinc-bound thymulin (ZnFTS) (AT) and total thymulin (TT) (active zinc-bound ZnFTS + inactive zinc-unbound FTS) after in vitro zinc addition to plasma samples. The ratio between TT/AT is the non-saturable fraction of thymulin (FTS) by zinc ions. Because of the existence of a strict inverse correlation between plasma zinc levels and the ratio itself, the latter is a good marker to detect zinc ion bioavailability and, consequently, the real zinc deficiency. The following cut-off points were established: (i) TT/AT \> 2 (log~−2~) = marked zinc deficiency; (ii) TT/AT \< 2 (log~−2~) = mild zinc deficiency; (iii) TT/AT = 1 (log~−2~): normal zinc values ([@BIB25]). This methodological procedure has led us to identify low zinc ion bioavailability in ageing and in various pathologies despite plasma zinc levels in the normal range ([Table 1](#TBL1){ref-type="table"} ). This also led us to seek the possible biological causes of low zinc ion bioavailability in ageing. Zinc-binding proteins, such as the metallothioneins (MT), are involved due to their higher binding affinity (kd = l0^−13^ M) for zinc compared to thymulin (10^−7^ M) (see [@BIB53]). However, this does not exclude other zinc-binding proteins with higher kd, such as α − 2 macroglobulin (10^−10^ M), from being increased in ageing and inflammation ([@BIB10]). MT bind preferentially to zinc rather than copper in ageing ([@BIB35]) and more zinc ions bound to MT in old liver than young (E. Mocchegiani, unpublished results). This last recent finding by our laboratory strongly suggest MTs as sequesters of zinc in constant stress, such as in ageing, inducing low zinc ion bioavailability for normal immune responses ([@BIB53]). As such, MT may move from having a protection in young-adults to a dangerous one for immune responses in the aged ([@BIB60], [@BIB53]). On the other hand, MT mRNA is increased in ageing ([@BIB60]) associated with impaired immune functions (NK activity) also during the circadian cycle ([@BIB54]). Therefore, high zinc-bound MT is deleterious for immune efficiency in ageing. Because of no significant, further increments of already high liver MT levels by zinc in old mice ([@BIB57]), zinc supplementation can be recommended in ageing in order to keep the immune system more efficient by means of major zinc ion bioavailability. Subsequent limited appearance of infections or relapses in elderly population may occur. Indeed low zinc bioavailability is a risk factor for immune deficiency and subsequent infection relapses in elderly population ([@BIB58]). On the other hand, high MT levels are present in lymphocytes of old people ([@BIB95]) suggesting also the measure of zinc content in lymphocytes may be misleading in testing zinc ion bioavailability. Following these considerations physiological supplementation of zinc (RDA) ([@BIB88]) was carried out in ageing and in syndromes of accelerated ageing (Down\'s syndrome) for short periods, even knowing the possible harmful effect of zinc toxicity in immune responses ([@BIB13]). However, there is no general consensus for supplementing zinc in Down\'s syndrome (DS) and in physiological ageing because contradictory data exist in real zinc deficiency. Indeed, some authors have reported normal or slightly reduced zinc content in lymphocytes of Down\'s syndrome subjects ([@BIB46]) and in the elderly population ([@BIB6]) with modest effects on immune efficiency. This may also be misleading, because, despite plasma zinc levels in the normal range for age in DS and ageing ([@BIB25]), the TT/AT ratio is \>2 (log~−2~) ([Table 1](#TBL1){ref-type="table"}) suggesting the presence of low zinc ion bioavailability in both conditions. In agreement with others ([@BIB82], [@BIB43]), physiological supplementing zinc (lozenge of 12 μg Zn^++^/day) for one or two months in elderly populations and in DS restores immune responses, and decreases oxidative damage with no modifications to copper levels ([@BIB24]). Reductions (more than 50%) of infectious episodes in DS and elderly subjects occur after zinc treatment with maintenance of good health and better cognitive performance also after 4 months and 1 yr of follow-up ([@BIB24], [@BIB39], [@BIB29], [@BIB58]). Similarly, physiological zinc treatment (18 μg Zn^++^/day) in drinking water in presenescent mice (from the age of 12 months) restores immune responses with reduction of mortality (35%) by infections of mycoplasma pulmonis or coronavirus murini with consequent significant prolonged survival as compared to normal mice ([@BIB59], [@BIB56]). Moreover, supplementing zinc restores the Th1/Th2 balance in an elderly population ([@BIB11]). It is also of interest to note that supplementing zinc is of benefit in restoring immune efficiency and subsequent significant reductions of infections relapses also in young-adult people affected by various pathological conditions ([Table 2](#TBL2){ref-type="table"} ). Therefore, zinc is crucial to maintain normal immune efficiency against infections over the entire life span. As a consequence, the lack of zinc ion bioavailability is pivotal to better understand the possible causes of immunosenescence.Table 1TT/AT ratio and plasma zinc levels in the elderly population and in various conditions[a](#TBLFN1){ref-type="table-fn"}ConditionAge (range years)TT/AT (range log~−2~)Plasma zinc levels (range μg/dl)*r*Elderly population60--832--380--95−0.77 (*P* \< 0.01)Alzheimer\'s Dementia70--752--380--90−0.67 (*P* \< 0.05)AIDS20--355--677--95−0.82 (*P* \< 0.01)Down\'s syndrome8--254--585--120−0.85 (*P* \< 0.01)Cystic fibrosis2--134--565--89−0.87 (*P* \< 0.01)Diabetes juvenile type I20--373--490--120−0.80 (*P* \< 0.01)Head traumatic injury18--303--490--110−0.78 (*P* \< 0.01)Premature infants1--2 (months)3--4100--120−0.77 (*P* \< 0.01)Allergy (Asthma and atropy)3--151--2110--130−0.45 (not significant)Solid tumours (lung, colon, cervix, prostate)35--554--585--95−0.82 (*P* \< 0.01)Leukemia (ALL)2--144--580--120−0.68 (*P* \< 0.05)Chronic renal failure37--463--480--100−0.70 (*P* \< 0.05)Iperprolactinemia30--422--388--97−0.73 (*P* \< 0.05)Crohn\'s Disease40--552--385--95−0.75 (*P* \< 0.05)Dwarfism (children)5--152--387--100−0.78 (*P* \< 0.01)Dwarfism (adult)27--452--380--95−0.66 (*P* \< 0.05)[^1]Table 2Benefit of physiological zinc (RDA) as resistance to infections in humans[a](#TBLFN2){ref-type="table-fn"}Time of treatmentCondition% of infections reduction2 monthsDown\'s syndrome (Bronchitis, Gastrointestinal infections)502 monthsMalnutrition (Gastrointestinal infections)352 monthsAcrodermatitis enteropathica (Skin lesions, Gastrointestinal infections)381 monthCongenital herpes (herpes simplex II)502 monthsLeprosy402 monthsMalaria352 monthsChronic diarrhea (*Salmonella*)301 monthAcute lower respiratory infections (Bronchitis)352 monthsBurns (Skin lesions, Bronchopneumonia)301 monthAIDS (*Candida albicans*, *Pneumocistis carinii*, *Toxoplasma gondii*, *Cytomegalovirus*, *Criptococcus*, *Salmonella*, *Mycobacterium tuberculosis*)551--3 monthsElderly population (Chronic Bronchitis Obstructive, Bronchopneumonia)301 yearSickle cell disease (Bronchitis and Urinary tract infections)503 weeksPregnancy (Bacterial Vaginosis)531 monthPreschool children (Malaria)552 monthsCommon cold (cough, fever, respiratory tract secretions)50[^2]

4. Zinc interaction with other micronutrients and zinc toxicity
===============================================================

The beneficial effect of physiological zinc supplementation on the immune system must be, however, related to the competition phenomena between zinc and several cations such as cadmium, lead, calcium, iron, manganese and copper. Beneficial effects of zinc on ameliorating toxicity of cadmium and lead, accentuation of zinc deficiency by administration of calcium and phytate, and production of hypocupremia by excessive zinc intake in humans and animal models, are some of the examples of competition phenomena ([@BIB36]). Such competition occurs, because these ions have similar valence shell electronic structure and, therefore, can be antagonists to each other biologically. Copper, zinc and cadmium with similar orbitals, configurations and coordination numbers have been shown to interact with each other ([@BIB38]). Such interactions occur between zinc and iron (Fe^++^) at the level of cysteine-histidine ligands for the formation of iron or zinc fingers proteins ([@BIB69]). In the course of an excess of iron, a preferential binding of iron over zinc with the metal free-protein occurs. The binding of iron results, however, in the loss of nucleic acid-binding activity ([@BIB42]). An excess of zinc as well as zinc deficiency impairs DNA-protein interactions of zinc finger domains with their cognate DNA target sites ([@BIB86]). As a result, the production of some transcriptional factors (SP1, TFIIIA) relevant for cell proliferation and differentiation is impaired ([@BIB86]). The same impairment of zinc finger DNA domains occurs in excess or deficiency of copper ([@BIB86]). This reinforces the notion of the relevance of interactions between zinc and copper and, more in general, also with other metals in the efficiency of immunity ([@BIB13]). Thus, a limited range of bioavailability exists for each metal: it may be narrow for some and broad for others. Indeed, the beneficial effect of zinc is strictly dependent on the dose and the length of the treatment. Zinc accumulation or imbalance of zinc-to-copper ratios may occur despite low doses of zinc ([@BIB23]). Thus, harmful side effects on the cardiovascular system and brain may appear with increases of both low density lipoprotein and cholesterol ([@BIB30]), and neural cell-death ([@BIB41]). Therefore, caution in zinc supplementation is warranted for successful treatment and to avoid undesirable and harmful side effects. Zinc supplementation must not exceed 2--3 times the RDA/day, for short periods (1--2 months) and in periodical cycles. Such a treatment does not interfere with copper absorption ([@BIB23]). Zinc in picolinate form is the best supplement ([@BIB90]).

5. Biochemical pathways of zinc affecting immunoresistance to infections in ageing
==================================================================================

The mechanism/s by which zinc may affect the immune system are multifaceted due to zinc\'s widespread action on different enzymes, peptides, transcriptional factors and cytokines involved in various physiological steps of immune development and reactivity. The main biochemical pathways of zinc with possible relevance to immunoresistance to infections in ageing are summarised in [Table 3](#TBL3){ref-type="table"} . Zinc directly influences immune cells by means of multiple enzymes at the level of replication and transcription. These include DNA and RNA polymerases, thymidine-kinase, terminal deoxyribonucleotidyl transferase, and ornithine decarboxylase. All these enzymes are zinc-dependent and involved in mitosis ([@BIB14]). Other zinc-dependent enzymes, such as nucleoside phosphorylase, ecto-5 nucleotidase and protein kinase C (PKC) are directly involved in zinc affects on the immune system because of their presence on lymphocyte membranes ([@BIB69]). Thus, zinc affects membrane stability by competing with thiols and influencing peroxidative damage ([@BIB4]). In addition, zinc protects against oxidative stress by pro-inflammatory cytokines with transcriptional factor (NF-kB and AP-1) activation ([@BIB37]). This occurs, because transcriptional factors NF-kB and AP-1 as well as many others involved in cell proliferation or in preventing apoptosis (MTF-1, RING, TFIIIA, EGR-1, EGR-2, BTE, WT-1, TRAF-2, ZEB, KS-1) contain zinc finger-like domains that are influenced by changes in the intracellular pool of zinc ([@BIB79], [@BIB74]). Moreover, zinc plays a role in T-lymphocyte activation by means of tyrosine kinase p56^lck^, an essential protein in the early steps of activation. Zinc stimulates autophosphorylation of tyrosine residues by p56^lck^ and subsequent phosphorylation of the antigen receptor complex involving CD45 ([@BIB67]). Reduction of p56^lck^ activity, such as in ageing ([@BIB79]), could reduce the ability of chemokine receptors on T-cells to bind the CC or CXC families of chemokines. This would result in a reduction in the migration of naive T-cells into inflammatory sites and subsequent formation of primed memory T-cells which seem reduced in aged mice ([@BIB8]). By contrast, normal zinc turnover induces p56^lck^ to inhibit viral penetration by phosphorylation of membrane proteins via PKC ([@BIB65]). A relevant pathway of zinc in affecting the immune system is related to the discovery of apoptosis prevention by zinc. Apoptosis is a mechanism involved in decreased immune responses during ageing and infections ([@BIB61], [@BIB79]), and low zinc bioavailability is a usual event in both conditions ([@BIB23]). Although, apoptosis prevention is dependent on zinc dose ([@BIB31]), the mechanisms by which zinc prevents apoptosis apply at multiple levels. Inhibition of Ca^++^/Mg^++^ DNA endonuclease activity, activation of nuclear factors NF-kB and AP-1, inhibition of caspase-3, increase of the Bcl-2/Bax ratio, and blockade of the ligand binding glucocorticoid receptors are the most studied. Zinc prevents apoptosis in ageing, especially by endonuclease enzymes activation ([@BIB31]), or by the blockade of the ligand binding glucocorticoid receptors ([@BIB72]). Another direct pathway is related to the discovery of zinc requirement in the biological activity of a thymic hormone, called thymulin (ZnFTS), which is essential in T-cell maturation and differentiation, in cytokine production, in natural killer cell activity and, consequently, in the efficiency of the entire immune system in host defence ([@BIB20], [@BIB53]). As a consequence, a correct balance of Th1/Th2 cytokines occurs, as demonstrated in the elderly ([@BIB11], [@BIB73]). Such a paradigm may also include Th3 cells because of their control of IL-12 ([@BIB33]), which are in turn decreased in ageing and affected by zinc ([@BIB22]) and thymulin ([@BIB34]).Table 3Main biochemical pathways of zinc relevant to immunoresistance to infections in ageing[a](#TBLFN3){ref-type="table-fn"}*Direct effects*DNA-RNA polymerases activationThymidine--Kinase activationTerminal deoxyribonucleotidyl transferase activationOrnithine decarboxylase activationEcto-5 nucleotidase activationProtein Kinase-C activationMembrane stability (competing with thiols)Transcriptional factor activation (NF-kB, AP-1)Apoptosis preventionThymulin activation (ZnFTS)Balance of Th1/Th2/Th3 paradigm (with subsequent cytokine production)MHC class II restricted activationp56^lck^ autophosphorylation  *Indirect effects*Endocrine cell activation (pineal gland, thyroid gland, adenohypophysis, β-cells of pancreas)Hormone receptor superfamily activation (melatonin, growth hormone, Nerve Growth Factor, insulin, IGF-I, thyroid hormones)Metallothioneins-Nitric-oxide-PARP homeostasis[^3]

Among the indirect pathways, the action of immunomodulating hormones \[melatonin, growth hormone, thyroid hormones (T~3~ and T~4~) and insulin-like growth factor-1 (IGF-1)\] has been recently proposed, because all these hormones can also affect immunity by means of the zinc pool ([@BIB53], [@BIB59]). These are, in turn, required to activate nuclear hormone receptors ([@BIB26]). An indirect pathway of zinc as an antioxidant ([@BIB9]), the homeostasis among zinc-bound MT, NO and PARP has been recently proposed, because it is related to the presence of massive and constant stress in ageing ([@BIB55]). Because of strict links between MT and NO and between NO and PARP, in turn, controlled by the pro-inflammatory cytokines (IL-1 and IL-6) and zinc turnover (see [@BIB55]), an alteration in one step of this homeostasis may finally divert PARP towards cell-death rather than DNA-repair. Indeed, zinc-bound MT are increased in ageing and acquire a dangerous role for immunity ([@BIB60]). NO is also augmented in ageing ([@BIB12]) with the final result of no protective role by NO against oxidative damage ([@BIB49]) and no prevention of apoptosis induced by PARP ([@BIB68]). In contrast, moderate stress in normal zinc bioavailability triggers PARP for DNA repair, as in young-adults ([@BIB19]). Therefore, altered zinc turnover might be the "primus movens" of decreased immunoresistance to infections in ageing by means of this altered biochemical homeostasis, via pro-inflammatory cytokines ([@BIB55]). Supplementation of zinc in ageing may correct the defect. Indeed, the increase of MT mRNA caused by zinc ([@BIB17]) does not affect the already high liver MT levels ([@BIB57]). This suggests that MT are saturated by pre-existing zinc ions in ageing. The increased MT mRNA acts as a reserve in MT production for a prompt response against continuous oxidative damage ([@BIB56], [@BIB57]) normally affecting NO and PARP activity, as it occurs in young-adult age. In addition, MT regain their original role of protection in releasing zinc to superoxide dismutase (SOD) ([@BIB47]), which is decreased in ageing with subsequent cellular oxidative damage ([@BIB53]). Analagously, the same phenomenon of regained protection occurs for increased alpha-2 macroglobulin in cancer as a result of zinc supplementation ([@BIB52]). Therefore, supply zinc in ageing is of benefit either to regain MT role of protection or to induce more zinc ion bioavailable in immune efficiency and in NO normal activity, as recently suggested by [@BIB81].

6. Conclusions and future prospects
===================================

Zinc is required as a catalytic, structural and regulatory ion for enzymes, proteins and transcription factors. Therefore, it is a key trace element for many body homeostatic mechanisms, including immune responses. Low zinc ion bioavailability results in limited immunoresistance to infections in ageing. Physiological supplementation of zinc for 1--2 months restores immune responses, thereby, reducing the incidence of infections and, consequently, prolonging survival ([@BIB1]). Its use may be of relevance in poor developing countries thanks to the low cost of zinc, where infection incidence is high ([@BIB77], [@BIB5]).

Among the biochemical pathways of zinc which affect the immune system, zinc-bound MT, NO and PARP homeostasis, via pro-inflammatory cytokines, is also involved because pro-inflammatory cytokines, MT and NO are all increased in ageing. Since NO activates PARP, which has a double role (DNA-repair or cell-death depending on the level of oxidative stress which can be massive in ageing ([@BIB12])), PARP activity may be addressed towards cell-death rather than DNA-repair ([@BIB68]) ([Fig. 1](#FIG1){ref-type="fig"} ). Zinc supplementation in ageing might nonetheless restore the DNA repair function of PARP. This last point is under investigation. Moreover, normal PARP and NO activities are implicated in healthy longevity ([@BIB62], [@BIB21] [@BIB93]). Because of increased MT in the liver and atrophic thymus of old mice ([@BIB53]), their normal production may also be involved in facilitating healthy longevity. Polymorphisms within the human genes encoding NO synthases, PARP and MT exist ([@BIB48], [@BIB91]). The data are, however, fragmentary limited to each factor alone. Genetic studies must be performed in the context of more genes ([@BIB78]). Therefore, the genetic study of this homeostasis in its totality might provide insight into possible biological and genetic markers of immunosenescence. These genetic studies are currently in progress in our laboratory.Fig. 1Possible different role of MTs during the whole life. Protective in young-adult age and dangerous in old age with final results of DNA-repair or cell-death by PARP, respectively. This is strictly dependent by oxidative and nitrosative stress status which is moderate in young age, massive in old age ([@BIB55]). Hatched line, very old age; ?, currently under investigation in our laboratory.
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[^1]: Normal levels of plasma zinc (range) for age (Immunology Ctr. INRCA, Ancona, Italy): 1--20 yr=120--150 μg/dl; 21--40 yr=95--120 μg/dl; 41--60 yr=80--95 μg/dl; 61--80 yr=80--87 μg/dl; \>80 yr=70--80 μg/dl. Coefficient of inverse correlation (*r*) between TT/AT and plasma zinc levels for single condition was calculated also adding data of respective age-matched healthy controls or young-adult healthy people for elderly people ([@BIB23]). Range TT/AT=1--1.5 (log~−2~) in healthy controls. ([@BIB25]). Normal zinc ion bioavailability exists in allergy.

[^2]: Infections or symptoms related to the condition are in brackets (for specific references, see [@BIB23], [@BIB79]).

[^3]: See for specific references: [@BIB79], [@BIB74], [@BIB55], [@BIB31].
